Health Canada Approves Moderna’s mRNA Flu and Combo Vaccines
Health Canada has granted authorization for both Moderna’s mRNA influenza vaccine and its combination mRNA vaccine targeting both flu and COVID-19 for adults 50 and older. The federal health agency informed the company that its flu vaccine, mFLUSIVA, and its combined flu and COVID-19 shot, mCOFLU, received approval on Nov. 5, a Moderna spokesperson has […]
Health Canada has approved Moderna’s mRNA influenza vaccine, mFLUSIVA, and its combination mRNA vaccine for flu and COVID-19, mCOFLU. These authorizations are for adults aged 50 and older. Canada is the first country to authorize both of these vaccines from Moderna.
- Health Canada authorized Moderna’s mRNA influenza vaccine (mFLUSIVA).
- Health Canada authorized Moderna’s combination mRNA vaccine for flu and COVID-19 (mCOFLU).
- Both vaccines are approved for adults aged 50 and older.
- Approval was granted on November 5.
- Canada is the first country to authorize both vaccines.
Write a comment